OBJ 4.17% 2.3¢ obj limited

Analgesics GSK...Love it

  1. 3,340 Posts.
    lightbulb Created with Sketch. 2
    Analgesics programme is looking very interesting and now the tie up with GSK is likely expanding to Novartis, NICE ONE.

    With phase I and II formulation, development and evaluations successfully completed they are well on their way to creating a massive ongoing opportunity with this Analgesics.

    For me Body Guard is extremely exciting and the Analgesic opportunity has moved from being very interesting to extremely exciting.

    Both have huge revenue/volume potential!!!

    Their is now no doubt that OBJ is going to prosper significantly from its technology foray into cosmetic industry.

    It was a shame about the Toothbrush, thank God we are not a one product show; and P&G are going gang busters with an expanding portfolio opportunity, they must love what they are seeing.

    All IMO of course.
watchlist Created with Sketch. Add OBJ (ASX) to my watchlist
(20min delay)
Mkt cap $41.61M
Open High Low Value Volume
2.2¢ 2.4¢ 2.2¢ $65.91K 2.887M

Buyers (Bids)

No. Vol. Price($)
1 11200 2.3¢

Sellers (Offers)

Price($) Vol. No.
2.4¢ 400000 2
Last update - 13.17pm 19/10/2018 (20 minute delay) ?
-0.00 ( 4.17 %)
Open High   Low Volume
2.2¢ 2.3¢   2.2¢ 577600
Last updated 12.07pm 19/10/2018 (live) ?
OBJ (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.